Melior Discovery, Inc Email Format

Research ServicesPennsylvania, United States11-50 Employees

Melior Discovery, Inc. is a research services firm based in Exton, Pennsylvania. It has developed a high-throughput in vivo pharmacology platform called theraTRACE, designed to identify new indications for preclinical and development-stage drugs. The platform is used by multinational pharmaceutical companies and startup biopharmaceutical firms to evaluate potential new uses for their drug candidates.

Beyond its discovery platform, Melior offers onshore preclinical services, including in vivo efficacy models across therapeutic areas, pharmacokinetic evaluations, specialized animal models, and bioanalytical services for drug developers worldwide. The company sits in the research services sector, providing capabilities from early discovery through preclinical testing. In September 2020, Melior formed a collaboration with Visikol to provide a mouse carbon tetrachloride–induced liver fibrosis model, extending its in vivo testing offerings.

Sign up for free to view info

Company overview Employee directory